|
|
||||||||
-mediated fibrotic responses in the lung
1 Department of Pathology and Molecular Medicine and Centre for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada L8N 3Z5; 2 Medizinische Klinik, Julius-Maximilians-Universität, 97080 Würzburg, Germany; and 3 University of Rochester School of Medicine, Rochester, New York 14642-8692
Transforming growth factor (TGF)-
is a key cytokine in
the pathogenesis of pulmonary fibrosis, and pharmacological
interference with TGF-
can ameliorate the fibrotic tissue response.
The small proteoglycans decorin and biglycan are able to bind and
inhibit TGF-
activity in vitro. Although decorin has anti-TGF-
properties in vivo, little is known about the physiological role of
biglycan in vivo. Adenoviral gene transfer was used to overexpress
active TGF-
, decorin, and biglycan in cell culture and in murine
lungs. Both proteoglycans were able to interfere with TGF-
bioactivity in vitro in a dose-dependant manner. In vivo,
overexpression of TGF-
resulted in marked lung fibrosis, which was
significantly reduced by concomitant overexpression of decorin.
Biglycan, however, had no significant effect on lung fibrosis induced
by TGF-
. The data suggest that differences in tissue distribution
are responsible for the different effects on TGF-
bioactivity in
vivo, indicating that decorin, but not biglycan, has potential
therapeutic value in fibrotic disorders of the lung.
pulmonary fibrosis; extracellular matrix; treatment
This article has been cited by other articles:
![]() |
T. Gambichler, A. Kreuter, M. Skrygan, B. Burkert, P. Altmeyer, and G. Schieren Decorin Is Significantly Overexpressed in Nephrogenic Systemic Fibrosis Am J Clin Pathol, July 1, 2009; 132(1): 139 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Khan, E. S. Muise, P. Iyengar, Z. V. Wang, M. Chandalia, N. Abate, B. B. Zhang, P. Bonaldo, S. Chua, and P. E. Scherer Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI Mol. Cell. Biol., March 15, 2009; 29(6): 1575 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Scotton and R. C. Chambers Molecular Targets in Pulmonary Fibrosis: The Myofibroblast in Focus Chest, October 1, 2007; 132(4): 1311 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Zhao and F. M. Hoffmann Inhibition of Transforming Growth Factor-beta1-induced Signaling and Epithelial-to-Mesenchymal Transition by the Smad-binding Peptide Aptamer Trx-SARA Mol. Biol. Cell, September 1, 2006; 17(9): 3819 - 3831. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pini, C. Torregiani, J. G. Martin, Q. Hamid, and M. S. Ludwig Airway remodeling in allergen-challenged Brown Norway rats: distribution of proteoglycans Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1052 - L1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Todorova, E. Gurcan, A. Miller-Larsson, and G. Westergren-Thorsson Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 92 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Frevert and P. L. Sannes Matrix proteoglycans as effector molecules for epithelial cell function Eur. Respir. Rev., December 1, 2005; 14(97): 137 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aoki, M. Kurabayashi, Y. Hasegawa, and I. Kojima Attenuation of Bleomycin-induced Pulmonary Fibrosis by Follistatin Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Buczek-Thomas, E. C. Lucey, P. J. Stone, C. L. Chu, C. B. Rich, I. Carreras, R. H. Goldstein, J. A. Foster, and M. A. Nugent Elastase Mediates the Release of Growth Factors from Lung In Vivo Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Bechara, L. A. S. Brown, J. Roman, P. C. Joshi, and D. M. Guidot Transforming Growth Factor {beta}1 Expression and Activation Is Increased in the Alcoholic Rat Lung Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 188 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimizu-Hirota, H. Sasamura, M. Kuroda, E. Kobayashi, M. Hayashi, and T. Saruta Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration Circ. Res., April 30, 2004; 94(8): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, K.-F. Beck, I. Raslik, S. Walpen, D. Mihalik, M. Micegova, K. Macakova, E. Schonherr, D. G. Seidler, G. Varga, et al. Biglycan, a Nitric Oxide-regulated Gene, Affects Adhesion, Growth, and Survival of Mesangial Cells J. Biol. Chem., July 3, 2003; 278(28): 26227 - 26237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Troup, C. Njue, E. V. Kliewer, M. Parisien, C. Roskelley, S. Chakravarti, P. J. Roughley, L. C. Murphy, and P. H. Watson Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer Clin. Cancer Res., January 1, 2003; 9(1): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kolb, P. Bonniaud, T. Galt, P. J. Sime, M. M. Kelly, P. J. Margetts, and J. Gauldie Differences in the Fibrogenic Response after Transfer of Active Transforming Growth Factor-{beta}1 Gene to Lungs of "Fibrosis-prone" and "Fibrosis-resistant" Mouse Strains Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 141 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, K. Macakova, I. Raslik, M. Micegova, H.-J. Grone, E. Schonherr, H. Robenek, F. G. Echtermeyer, S. Grassel, P. Bruckner, et al. Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction Am. J. Pathol., March 1, 2002; 160(3): 1181 - 1191. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |